JIN Net Debt from 2010 to 2024

ZJYL Stock

0.91 0.07 7.14%

JIN MEDICAL Net Debt yearly trend continues to be quite stable with very little volatility. The value of Net Debt is projected to decrease to about -2.7 M. Net Debt is the total debt of JIN MEDICAL INTERNATIONAL minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2010-12-31

Previous Quarter

-2.5 M

Current Value

-2.7 M

Quarterly Volatility

2.1 M

Credit Downgrade

Yuan Drop

Covid

Check JIN MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JIN MEDICAL's main balance sheet or income statement drivers, such as Depreciation And Amortization of 254.9 K, Interest Expense of 8.1 K or Selling General Administrative of 2 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0 or PTB Ratio of 0.39. JIN financial statements analysis is a perfect complement when working with JIN MEDICAL Valuation or Volatility modules.

Check out the analysis of JIN MEDICAL Correlation against competitors.

Latest JIN MEDICAL's Net Debt Growth Pattern

Below is the plot of the Net Debt of JIN MEDICAL INTERNATIONAL over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. JIN MEDICAL's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in JIN MEDICAL's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

JIN Net Debt Regression Statistics

	Arithmetic Mean	(475,025)
	Coefficient Of Variation	(447.50)
	Mean Deviation	1,880,365
	Median	929,863
	Standard Deviation	2,125,726
	Sample Variance	4.5T
	Range	5.8M
	R-Value	(0.76)
	Mean Square Error	2T
	R-Squared	0.58
	Significance	0.001
	Slope	(361,604)
	Total Sum of Squares	63.3T

JIN Net Debt History

	2024	-2.7 M
	2023	-2.5 M
	2022	-2.8 M
	2021	-4.8 M
	2020	-3.7 M
	2019	983.7 K

Other Fundumenentals of JIN MEDICAL INTERNATIONAL

Net Debt To E B I T D A

JIN MEDICAL Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital
Total Assets		0.98	0.84	-0.44	-0.54	0.89	-0.87	-0.36	0.92	-0.36	1.0	0.78	-0.84	-0.6	-0.83	0.99	0.79	0.98	0.97
Total Stockholder Equity	0.98		0.93	-0.41	-0.7	0.96	-0.88	-0.51	0.9	-0.52	0.98	0.88	-0.84	-0.69	-0.92	0.98	0.89	0.94	1.0
Net Tangible Assets	0.84	0.93		-0.25	-0.9	0.98	-0.77	-0.66	0.78	-0.76	0.85	0.98	-0.76	-0.82	-0.96	0.84	0.99	0.8	0.93
Current Deferred Revenue	-0.44	-0.41	-0.25		0.01	-0.35	0.68	0.07	-0.47	0.13	-0.44	-0.1	0.63	0.07	0.43	-0.48	-0.11	-0.49	-0.41
Net Debt	-0.54	-0.7	-0.9	0.01		-0.84	0.55	0.87	-0.59	0.91	-0.56	-0.9	0.58	0.84	0.87	-0.54	-0.93	-0.48	-0.7
Retained Earnings	0.89	0.96	0.98	-0.35	-0.84		-0.81	-0.67	0.85	-0.69	0.9	0.93	-0.82	-0.85	-0.98	0.89	0.95	0.85	0.96
Accounts Payable	-0.87	-0.88	-0.77	0.68	0.55	-0.81		0.44	-0.9	0.52	-0.87	-0.69	0.94	0.43	0.85	-0.88	-0.7	-0.87	-0.88
Net Receivables	-0.36	-0.51	-0.66	0.07	0.87	-0.67	0.44		-0.5	0.78	-0.38	-0.64	0.48	0.76	0.74	-0.37	-0.7	-0.24	-0.52
Short Term Investments	0.92	0.9	0.78	-0.47	-0.59	0.85	-0.9	-0.5		-0.5	0.91	0.7	-0.95	-0.61	-0.85	0.88	0.74	0.91	0.89
Total Liab	-0.36	-0.52	-0.76	0.13	0.91	-0.69	0.52	0.78	-0.5		-0.38	-0.74	0.61	0.7	0.8	-0.35	-0.78	-0.36	-0.51
Total Current Assets	1.0	0.98	0.85	-0.44	-0.56	0.9	-0.87	-0.38	0.91	-0.38		0.8	-0.84	-0.61	-0.84	1.0	0.8	0.97	0.98
Short Term Debt	0.78	0.88	0.98	-0.1	-0.9	0.93	-0.69	-0.64	0.7	-0.74	0.8		-0.66	-0.76	-0.91	0.79	0.99	0.73	0.89
Intangible Assets	-0.84	-0.84	-0.76	0.63	0.58	-0.82	0.94	0.48	-0.95	0.61	-0.84	-0.66		0.56	0.87	-0.82	-0.7	-0.87	-0.83
Common Stock	-0.6	-0.69	-0.82	0.07	0.84	-0.85	0.43	0.76	-0.61	0.7	-0.61	-0.76	0.56		0.82	-0.58	-0.83	-0.54	-0.69
Property Plant Equipment	-0.83	-0.92	-0.96	0.43	0.87	-0.98	0.85	0.74	-0.85	0.8	-0.84	-0.91	0.87	0.82		-0.83	-0.93	-0.8	-0.92
Net Invested Capital	0.99	0.98	0.84	-0.48	-0.54	0.89	-0.88	-0.37	0.88	-0.35	1.0	0.79	-0.82	-0.58	-0.83		0.78	0.96	0.98
Short Long Term Debt	0.79	0.89	0.99	-0.11	-0.93	0.95	-0.7	-0.7	0.74	-0.78	0.8	0.99	-0.7	-0.83	-0.93	0.78		0.74	0.89
Capital Stock	0.98	0.94	0.8	-0.49	-0.48	0.85	-0.87	-0.24	0.91	-0.36	0.97	0.73	-0.87	-0.54	-0.8	0.96	0.74		0.93
Net Working Capital	0.97	1.0	0.93	-0.41	-0.7	0.96	-0.88	-0.52	0.89	-0.51	0.98	0.89	-0.83	-0.69	-0.92	0.98	0.89	0.93

Click cells to compare fundamentals

About JIN MEDICAL Financial Statements

JIN MEDICAL investors utilize fundamental indicators, such as Net Debt, to predict how JIN Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-2.5 M	-2.7 M
Net Debt To EBITDA	(1.05)	(1.10)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:

How To Invest In JIN

Details

Is JIN Stock a good investment?

Details

What is JIN MEDICAL's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of JIN MEDICAL Correlation against competitors.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.12)

Earnings Share

0.02

Revenue Per Share

0.129

Quarterly Revenue Growth

0.03

Return On Assets

0.0403

The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JIN Net Debt from 2010 to 2024

Latest JIN MEDICAL's Net Debt Growth Pattern

JIN Net Debt Regression Statistics

JIN Net Debt History

Other Fundumenentals of JIN MEDICAL INTERNATIONAL

JIN MEDICAL Net Debt component correlations

About JIN MEDICAL Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY